| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 1/6 |
Green Cross Holdings Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩16,910.00 |
| 52 Week High | ₩18,490.00 |
| 52 Week Low | ₩12,940.00 |
| Beta | 0.91 |
| 11 Month Change | 10.81% |
| 3 Month Change | 15.66% |
| 1 Year Change | 22.27% |
| 33 Year Change | -47.07% |
| 5 Year Change | -9.33% |
| Change since IPO | 926.03% |
Recent News & Updates
Recent updates
Is Green Cross Holdings (KRX:005250) Using Debt Sensibly?
Aug 09
Know This Before Buying Green Cross Holdings Corporation (KRX:005250) For Its Dividend
Apr 28Is Now The Time To Put Green Cross Holdings (KRX:005250) On Your Watchlist?
Mar 21Green Cross Holdings (KRX:005250) Seems To Be Using A Lot Of Debt
Mar 01If You Had Bought Green Cross Holdings (KRX:005250) Stock A Year Ago, You Could Pocket A 106% Gain Today
Feb 12Here's What Green Cross Holdings Corporation's (KRX:005250) Shareholder Ownership Structure Looks Like
Jan 28We're Not So Sure You Should Rely on Green Cross Holdings's (KRX:005250) Statutory Earnings
Jan 12
Green Cross Holdings Corporation (KRX:005250) Investors Should Think About This Before Buying It For Its Dividend
Dec 28Green Cross Holdings Corporation's (KRX:005250) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
Dec 13Green Cross Holdings (KRX:005250) Use Of Debt Could Be Considered Risky
Nov 28Optimistic Investors Push Green Cross Holdings Corporation (KRX:005250) Shares Up 63% But Growth Is Lacking
Nov 28Shareholder Returns
| A005250 | KR Biotechs | KR Market | |
|---|---|---|---|
| 7D | 4.8% | 1.5% | 1.9% |
| 1Y | 22.3% | 38.5% | 5.0% |
Return vs Industry: A005250 underperformed the KR Biotechs industry which returned 38.5% over the past year.
Return vs Market: A005250 exceeded the KR Market which returned 5% over the past year.
Price Volatility
| A005250 volatility | |
|---|---|
| A005250 Average Weekly Movement | 6.3% |
| Biotechs Industry Average Movement | 9.5% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in KR Market | 12.1% |
| 10% least volatile stocks in KR Market | 3.4% |
Stable Share Price: A005250 has not had significant price volatility in the past 3 months.
Volatility Over Time: A005250's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1967 | 150 | Il-Sup Huh | www.gcbiopharma.com |
Green Cross Holdings Corporation operates as a biotechnology company. The company provides prescription drugs and over the counter drugs; aseptic fill and finish services for drug manufacturing; and pharmaceutical logistics services. It also researches and develops plasma derivatives for von Willebrand disease and primary immunodeficiency; vaccines for mRNA flu, anthrax, tetanus, diphtheria, pertussis, tuberculosis, and varicella; recombinant treatments for acquired thrombotic thrombocytopenic purpura, fabry, hemophilia, hunterase, colon cancer, and hunter syndrome; and small molecules for gangliosidosis andalagille’s syndrome.
Green Cross Holdings Corporation Fundamentals Summary
| A005250 fundamental statistics | |
|---|---|
| Market cap | ₩767.03b |
| Earnings (TTM) | -₩68.77b |
| Revenue (TTM) | ₩2.09t |
0.4x
P/S Ratio-11.2x
P/E RatioIs A005250 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A005250 income statement (TTM) | |
|---|---|
| Revenue | ₩2.09t |
| Cost of Revenue | ₩1.50t |
| Gross Profit | ₩594.19b |
| Other Expenses | ₩662.96b |
| Earnings | -₩68.77b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.51k |
| Gross Margin | 28.44% |
| Net Profit Margin | -3.29% |
| Debt/Equity Ratio | 74.4% |
How did A005250 perform over the long term?
See historical performance and comparison